<DOC>
	<DOCNO>NCT02792205</DOCNO>
	<brief_summary>Von Willebrand Disease ( VWD ) define inherited bleeding disorder cause deficiency dysfunction von Willebrand factor ( VWF ) , plasma protein mediate initial adhesion platelet sit vascular injury also bind stabilizes blood clot factor VIII ( FVIII ) circulation . The severe form VWD usually easy diagnose ( obvious hemorrhagic symptom major VWF deficiency ) , whereas mild form disease still difficult confirm . It indeed report 1 % population carry mild biological VWF deficiency without bleed tendency `` actual disease '' . On contrary , patient severe bleed history carry true VWF abnormality , well-confirmed genetic study , without VWF deficiency evaluate standard biological method , Ristocetin Cofactor activity ( VWF : RCo ) . However , patient , use alternative method , PFA-100 ( Platelet Fonction Analyzer-100 ) , study Factor VIII ( FVIII : C ) VWF ( FVIII : C/VWF ) ratio evaluation VWF activity use specialize method VWF : CB ( VWF-Collagen Binding ) assay detect VWF deficiency possible hemorrhagic predisposition . In project , investigator plan assess performance VWF : CB diagnosis VWF deficiency patient unexplained bleed history .</brief_summary>
	<brief_title>Performance Evaluation Von Willebrand : Collagen-Binding Assays Diagnose Von Willebrand Factor Deficiency Patients With Increased Risk Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Von Willebrand Diseases</mesh_term>
	<criteria>Patient bleed history send Hemophilia Treatment Center Dijon Nantes University Hospital abnormal bleeding score ( &gt; 3 men &gt; 5 woman Patient provide sign consent participate study blood sample Affiliation French social security system Non Minors include study . Ongoing pregnancy postpartum period ( 3 month delivery ) Substitutive treatment coagulation factor concentrate desmopressin administration within 10 day sample . Ongoing infectious inflammatory disease modify VWF level . Diagnosis obvious hemostasis disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Willebrand factor deficiency</keyword>
	<keyword>hematology</keyword>
	<keyword>Willebrand : Collagen-binding</keyword>
</DOC>